Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2005
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1681835A Gene families associated with stomach cancer
10/12/2005CN1681834A Gene families associated with liver cancer
10/12/2005CN1680591A DNA fingerprint atlas of grass of Dalai and its obtaining method and special primer
10/12/2005CN1680422A Rapid extraction of RNA from cells and tissues
10/12/2005CN1680421A Adsorption of nucleic acids to a solid phase
10/12/2005CN1679929A Streptococcal c5a peptidase vaccine
10/12/2005CN1222618C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
10/11/2005USRE38825 Genes encoding a glyphosate oxidoreductase enzyme; useful in producing transformed bacteria and plants which degrade glyphosate herbicide; crop plants which are tolerant to glyphosate herbicide
10/11/2005US6953839 recombinant triple helical proteins; collagen-like peptides
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953690 Compositions and methods for helper-free production of recombinant adeno-associated viruses
10/11/2005US6953687 Biodrugs, viricides, antitumor agents, dna sequences having splicing sites, gene therapy for inhibiting viral replication, cancer growth
10/11/2005US6953668 Prostate-specific membrane antigen
10/11/2005US6953663 Polymorphism detection
10/06/2005WO2005093098A1 Differential drug sensitivity
10/06/2005WO2005093090A1 Antisense oligonucleotides and uses thereof in improving cancer treatment strategies
10/06/2005WO2005092911A1 Method for separating and purifying nucleic acid
10/06/2005WO2005092910A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/06/2005WO2005092909A1 Processes for producing ribonucleotide analogue with high stereoregularity and deoxyribonucleotide analogue
10/06/2005WO2005091992A2 Oligonucleotide compositions targeting egr-1 forcancer treatment
10/06/2005WO2005091777A2 Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides
10/06/2005WO2005091751A2 Novel gene associated with type 1 diabetes and methods of use
10/06/2005WO2005077126A9 Use of ppargamma specific inhibitors as anti-cancer therapeutics
10/06/2005WO2005072893A8 Functionalized colloidal metal compositions and methods
10/06/2005WO2005063997A3 Maize metallothionein promoter
10/06/2005WO2005052170A3 Gene silencing by using micro-rna molecules
10/06/2005WO2005049838A3 Syk-targeted nucleic acid interference
10/06/2005WO2005027844A3 Dna vaccine compositions and methods of use
10/06/2005WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna
10/06/2005WO2004080406A3 Therapeutic compositions
10/06/2005WO2004065570A3 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces
10/06/2005WO2004059279A3 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050223442 Nucleic acid sequences coding nicotine demethylase for use as tool in identifying modulators of nornicotine concentration in cells
10/06/2005US20050223441 Methods for increasing the amount of protein in potato tubers
10/06/2005US20050223427 Modified polynucleotides for reducing off-target effects in RNA interference
10/06/2005US20050223426 Maize cellulose synthases and uses thereof
10/06/2005US20050223418 Porcine CMP-N-Acetylneuraminic acid hydroxylase gene
10/06/2005US20050222698 Integrated configuration system for use in a process plant
10/06/2005US20050222403 Oligonucleotide probes for in vitro, in vivo and intra-cellular detection
10/06/2005US20050222402 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/06/2005US20050222401 Noved human proteases and polynucleotides encoding the same
10/06/2005US20050222400 Aptamer constructs
10/06/2005US20050222399 Bioinformatically detectable group of novel regulatory oligonucleotides associated with alzheimer's disease and uses thereof
10/06/2005US20050222389 Method for preparing modified polypeptides
10/06/2005US20050222385 Hybrid and tandem expression of neisserial proteins
10/06/2005US20050222073 Antisense modulation of thyroid hormone receptor interactor 6 expression
10/06/2005US20050222067 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050222066 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
10/06/2005US20050222063 Methylenetetrahydrofolate reductase inhibitors and use thereof
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/06/2005US20050222059 Egfrviii specific monoclonal antibody and egfrviii ribozymes and use to detect, treat or prevent egfrviii associated cancer
10/06/2005US20050222058 Antisense modulation of mucin 1, transmembrane expression
10/06/2005US20050222056 Heterocyclic compounds and their use in the detection of nucleic acids
10/06/2005US20050222035 Peptides and related molecules that modulate nerve growth factor activity
10/06/2005US20050222033 Receptor based antagonists and methods of making and using
10/06/2005US20050221490 DNA virus microRNA and methods for inhibiting same
10/06/2005US20050221461 Genetic engineered Dna; textile cleaning compounds
10/06/2005US20050221444 Expression cassette comprising a polypeptide with a promoter sequence, a translation initiation sequence, a first inclusion body fusion partner, suppressable stop codon,cleavable peptide linkers, a fusion tag, and a transcription terminator sequence; antidiabetic agents; viral infections
10/06/2005US20050221443 Tumor necrosis factor super family agonists
10/06/2005US20050221439 Genes of an otitis media isolate of haemophilus influenzae
10/06/2005US20050221438 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for grafting enhancement, graft versus host (GvH) inhibition, graft versus tumor (GvT) stimulation, for the prevention or therapy of tumors and/or of microorganism infections
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221433 IL-18 specific polypeptides and therapeutic uses thereof
10/06/2005US20050221430 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
10/06/2005US20050221429 Host cells containing multiple integrating vectors comprising an amplifiable marker
10/06/2005US20050221427 Method for screening restriction endonucleases
10/06/2005US20050221426 Polynucleotide having a sequence encoding a mutant cyclic nucleotide-gated channel with at least one mutation that decreases divalent cation-mediated blockage of cation flux; and at least one mutation that makes the channel more sensitive to cAMP than a channel that does not have the mutation
10/06/2005US20050221425 promoter is induced by a reduction in temperature; can be used for regulated expression of proteins, both homologous and heterologous, very efficiently and economically
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221394 Ion channel
10/06/2005US20050221378 Polynucleotides formed by hybridization of oligonucleotides, then ligation with synthetases and denaturing to form complementary DNA; genetic engineering
10/06/2005US20050221376 Metalloproteinase ADAM 22
10/06/2005US20050221371 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/06/2005US20050221370 Systems and methods for ordering, performing, and reporting genetic screening
10/06/2005US20050221359 Cospeptin, cosmedin and their uses
10/06/2005US20050221352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/06/2005US20050221343 Self-assembling split-fluorescent protein systems
10/06/2005US20050221342 Nucleic acids and polypeptides
10/06/2005US20050221340 Computer-directed assembly of a polynucleotide encoding a target polypetide
10/06/2005US20050221338 Novel fluorescent protein and gene encoding the same
10/06/2005US20050221328 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
10/06/2005US20050221318 Building block forming a c-c bond upon reaction
10/06/2005US20050221316 Method for synthesising templated molecules
10/06/2005US20050221311 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and used thereof
10/06/2005US20050221307 Stabilisation of double-stranded nuleic acids using proteins
10/06/2005US20050221301 Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1
10/06/2005US20050221293 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050221291 Dc-sign isoforms, related compositions and methods for their use in disease therapy
10/06/2005US20050221289 Altering viral tropism
10/06/2005US20050221288 Variant tat proteins and methods for use thereof
10/06/2005US20050220816 Mutant viral nucleic acids and vaccine containing same
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220800 Cytokines and cytokine receptors with reduced immunogenicity
10/06/2005US20050220792 Selective inhibition of NF-kappaB activation by peptides designed to disrupt NEMO oligomerization
10/06/2005US20050220789 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
10/06/2005US20050220781 IFIX, a novel HIN-200 protein, for cancer therapy
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 899